Latest Biotech Startup Funding Rounds
Financing for drug discovery, therapeutics and biological technologies, with the development context behind each round.
- Rounds
- 603 All time
- Disclosed funding
- $28.7B 480 disclosed amounts
- Median round
- $17M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| BB Barnwell BioCompany profile Provides metagenomic biosurveillance for poultry producers to detect disease threats early Provides metagenomic biosurveillance for poultry producers to detect disease threats early | $6M | Seed | Biotech | United States | Investors | |
| FB Fortitude BiomedicinesCompany profile Develops antibody-based therapies for autoimmune diseases and cancer Develops antibody-based therapies for autoimmune diseases and cancer | $13M | Seed | Biotech | United States | Investors | |
| RM Resolve M TherapeuticsCompany profile Builds pro-resolution platform for target ID and drug discovery for inflammatory diseases Builds pro-resolution platform for target ID and drug discovery for inflammatory diseases | Undisclosed | Undisclosed | Biotech | United States | Investors | |
| OB Octarine BioCompany profile Octarine Bio develops bio-based pigments through precision fermentation for textiles and other industrial applications. Octarine Bio develops bio-based pigments through precision fermentation for textiles and other industrial applications. | €5M | Series A extensionSeries A | Biotech | Denmark | Investors | |
| M Develops and commercializes rare disease therapies using AI | $82M | Series A | Biotech | United States | Investors | |
Corxel PharmaceuticalsCompany profile Corxel Pharmaceuticals develops clinical-stage medicines for cardiometabolic diseases, including obesity, diabetes, stroke and hypertension. Corxel Pharmaceuticals develops clinical-stage medicines for cardiometabolic diseases, including obesity, diabetes, stroke and hypertension. | ≤$287M | Series D1Series C+ | Biotech | China | Investors | |
| I InfinitopesCompany profile Develops precision therapeutic vaccines against multiple solid tumour indications Develops precision therapeutic vaccines against multiple solid tumour indications | $15.4M | Seed | Biotech | United Kingdom | Investors | |
Provides AI-powered commercial intelligence for Life Sciences organizations | $6M | Seed | Biotech | United States | Investors | |
| TB Think BioscienceCompany profile Develops small molecule drugs for historically challenging drug targets Develops small molecule drugs for historically challenging drug targets | $55M | Series A | Biotech | United States | Investors | |
| E ExcivaCompany profile Develops novel therapies for behavioral symptoms associated with Alzheimer's Disease Develops novel therapies for behavioral symptoms associated with Alzheimer's Disease | €51M | Series B | Biotech | Germany | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1RA Capital Management
Delix Therapeutics, Alethio Therapeutics, Estuary Biotherapeutics
27rounds6led - 2Eli Lilly and Company
Oyster Therapeutics, BigHat Biosciences, Circle Pharma, Inc.
16rounds0led - 3Janus Henderson Investors
Star Therapeutics, OMass Therapeutics, Soufflé Therapeutics
16rounds1led - 4ARCH Venture Partners
Soufflé Therapeutics, Encoded Therapeutics Inc., Moonwalk Biosciences
16rounds1led - 5OrbiMed
Dren Bio, Star Therapeutics, Leal Therapeutics
12rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.